89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,559,162 | -33.5% | 100,982 | -18.4% | 0.00% | 0.0% |
| Q2 2023 | $2,346,351 | +9.2% | 123,818 | -12.3% | 0.00% | 0.0% |
| Q1 2023 | $2,149,319 | +1568.5% | 141,124 | +1294.6% | 0.00% | – |
| Q4 2022 | $128,815 | -72.4% | 10,119 | -87.4% | 0.00% | – |
| Q3 2022 | $467,000 | +60.5% | 80,581 | -10.8% | 0.00% | – |
| Q2 2022 | $291,000 | +193.9% | 90,361 | +244.0% | 0.00% | – |
| Q1 2022 | $99,000 | +4.2% | 26,265 | +261.0% | 0.00% | – |
| Q4 2021 | $95,000 | +10.5% | 7,276 | +67.1% | 0.00% | – |
| Q3 2021 | $86,000 | -38.6% | 4,355 | -42.0% | 0.00% | – |
| Q2 2021 | $140,000 | -14.6% | 7,512 | +8.3% | 0.00% | – |
| Q1 2021 | $164,000 | +1.2% | 6,939 | +4.8% | 0.00% | – |
| Q4 2020 | $162,000 | +113.2% | 6,623 | +122.5% | 0.00% | – |
| Q3 2020 | $76,000 | -13.6% | 2,977 | -32.3% | 0.00% | – |
| Q2 2020 | $88,000 | -25.4% | 4,400 | -6.1% | 0.00% | – |
| Q1 2020 | $118,000 | -27.6% | 4,687 | -24.3% | 0.00% | – |
| Q4 2019 | $163,000 | – | 6,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $173,880,118 | 3.94% |
| Orchard Capital Management, LLC | 551,879 | $8,405,117 | 2.81% |
| Cormorant Asset Management, LP | 2,800,000 | $42,644 | 2.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 438,215 | $6,674,014 | 2.76% |
| Boxer Capital, LLC | 2,100,000 | $31,983 | 1.57% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,210,536 | $33,666,463 | 1.42% |
| Resolute Capital Asset Partners LLC | 125,000 | $1,904 | 1.39% |
| Velan Capital Investment Management LP | 98,500 | $1,500,155 | 1.28% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $3,046,000 | 1.26% |
| Deep Track Capital, LP | 1,800,000 | $27,414,000 | 1.13% |